L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab

Autor: Marrocco, Ilaria, Giri, Suvendu, Simoni-Nieves, Arturo, Gupta, Nitin, Rudnitsky, Anna, Haga, Yuya, Romaniello, Donatella, Sekar, Arunachalam, Zerbib, Mirie, Oren, Roni, Lindzen, Moshit, Fard, Damon, Tsutsumi, Yasuo, Lauriola, Mattia, Tamagnone, Luca, Yarden, Yosef
Zdroj: In Cell Reports Medicine 15 August 2023 4(8)
Databáze: ScienceDirect